AURORA CANNABIS REAFFIRMS RECOMMENDATION TO SHAREHOLDERS: REJECT CURALEAF'S REVISED HOSTILE BID; PRESERVE OPPORTUNITIES FOR FUTURE UPSIDE

AURORA URGES SHAREHOLDERS TO TAKE NO ACTION TO REVISED HOSTILE BID BY CURALEAF AS FORMAL REVIEW UNDERWAY

AURORA MAINTAINS SHAREHOLDER RECOMMENDATION TO TAKE NO ACTION AT THIS TIME AS CURALEAF HAS YET TO FILE THEIR REVISED HOSTILE BID

AURORA CANNABIS FILES APPLICATION WITH ALBERTA SECURITIES COMMISSION TO PROTECT COMPANY SHAREHOLDERS HAVING IDENTIFIED SEVERAL DEFICIENCIES IN CURALEAF'S HOSTILE BID DISCLOSURE

AURORA CANNABIS REFUTES CURALEAF'S LATEST ATTEMPT TO DISTRACT SHAREHOLDERS FROM THE FACTS

AURORA APPOINTS SEASONED BIOPHARMACEUTICAL EXECUTIVE TO LEAD COMMERCIAL ACCELERATION OF GLOBAL MEDICAL CANNABIS BUSINESS

AURORA CANNABIS URGES SHAREHOLDERS TO REJECT CURALEAF’S HOSTILE BID, WARNING THAT IT IS INADEQUATE, UNDERVALUES AURORA AND PUTS SHAREHOLDER VALUE AND FUTURE UPSIDE AT RISK

AURORA CANNABIS CORRECTS INACCURATE STATEMENTS MADE IN SUPPORT OF CURALEAF HOLDINGS' HOSTILE BID

AURORA CANNABIS INC. URGES SHAREHOLDERS TO TAKE NO ACTION AT THIS TIME IN RESPECT TO THE UNSOLICITED TAKE-OVER BID BY CURALEAF HOLDINGS, INC.

AURORA CANNABIS INC. RESPONDS TO PRESS RELEASE OF CURALEAF HOLDINGS, INC. REGARDING INTENTION TO LAUNCH UNSOLICITED TAKE-OVER BID